Pfizer Inc. (LON:0Q1N)
London
· Delayed Price · Currency is GBP · Price in USD 26.10
+0.10 (0.38%)
At close: Feb 21, 2025
Pfizer Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | - | 2,119 | 31,372 | 21,979 | 9,159 | Upgrade
|
| Depreciation & Amortization | - | 6,258 | 5,028 | 5,104 | 4,664 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 3,440 | 586 | 363 | 2,066 | Upgrade
|
| Stock-Based Compensation | - | 525 | 872 | 1,182 | 755 | Upgrade
|
| Other Operating Activities | - | -1,485 | -2,946 | -8,943 | -5,797 | Upgrade
|
| Change in Accounts Receivable | - | 347 | 261 | -3,811 | -1,275 | Upgrade
|
| Change in Inventory | - | -1,169 | -591 | -1,125 | -778 | Upgrade
|
| Change in Accounts Payable | - | -300 | 1,191 | 1,242 | 355 | Upgrade
|
| Change in Other Net Operating Assets | - | -1,050 | -6,500 | 16,498 | 1,391 | Upgrade
|
| Operating Cash Flow | - | 8,700 | 29,267 | 32,580 | 14,403 | Upgrade
|
| Operating Cash Flow Growth | - | -70.27% | -10.17% | 126.20% | 14.42% | Upgrade
|
| Capital Expenditures | - | -3,907 | -3,236 | -2,711 | -2,226 | Upgrade
|
| Cash Acquisitions | - | -43,430 | -22,997 | - | - | Upgrade
|
| Investment in Securities | - | 15,239 | 6,682 | -19,517 | -1,672 | Upgrade
|
| Other Investing Activities | - | -180 | 3,768 | -318 | -373 | Upgrade
|
| Investing Cash Flow | - | -32,278 | -15,783 | -22,546 | -4,271 | Upgrade
|
| Short-Term Debt Issued | - | 7,686 | 3,891 | - | 12,352 | Upgrade
|
| Long-Term Debt Issued | - | 30,831 | - | 997 | 5,222 | Upgrade
|
| Total Debt Issued | - | 38,517 | 3,891 | 997 | 17,574 | Upgrade
|
| Short-Term Debt Repaid | - | -3 | -4,109 | -96 | -26,326 | Upgrade
|
| Long-Term Debt Repaid | - | -2,569 | -3,298 | -2,004 | -4,003 | Upgrade
|
| Total Debt Repaid | - | -2,572 | -7,407 | -2,100 | -30,329 | Upgrade
|
| Net Debt Issued (Repaid) | - | 35,945 | -3,516 | -1,103 | -12,755 | Upgrade
|
| Repurchase of Common Stock | - | - | -2,000 | - | - | Upgrade
|
| Common Dividends Paid | - | -9,247 | -8,983 | -8,729 | -8,440 | Upgrade
|
| Dividends Paid | - | -9,247 | -8,983 | -8,729 | -8,440 | Upgrade
|
| Other Financing Activities | - | -632 | -335 | 16 | 11,546 | Upgrade
|
| Financing Cash Flow | - | 26,066 | -14,834 | -9,816 | -9,649 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -40 | -165 | -59 | -8 | Upgrade
|
| Net Cash Flow | - | 2,448 | -1,515 | 159 | 475 | Upgrade
|
| Free Cash Flow | - | 4,793 | 26,031 | 29,869 | 12,177 | Upgrade
|
| Free Cash Flow Growth | - | -81.59% | -12.85% | 145.29% | 15.51% | Upgrade
|
| Free Cash Flow Margin | - | 8.19% | 25.95% | 36.74% | 29.24% | Upgrade
|
| Free Cash Flow Per Share | - | 0.84 | 4.54 | 5.23 | 2.16 | Upgrade
|
| Cash Interest Paid | - | 2,215 | 1,442 | 1,467 | 1,641 | Upgrade
|
| Cash Income Tax Paid | - | 3,147 | 7,867 | 7,427 | 3,153 | Upgrade
|
| Levered Free Cash Flow | - | 1,024 | 24,957 | 30,940 | 10,761 | Upgrade
|
| Unlevered Free Cash Flow | - | 2,405 | 25,731 | 31,747 | 11,666 | Upgrade
|
| Change in Net Working Capital | - | 3,778 | 1,325 | -11,290 | -2,335 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.